Screener
ImmunityBio, Inc. IBRX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense related to revenue interest liability | (13,871) | (13,534) |
| Change in fair value of derivative liabilities | 1,108 | 5,578 |
| Interest expense | (34) | (18) |
| Other expense, net | (5,917) | (41) |
| Total other expense, net | (562,997) | (65,471) |
| Loss before income taxes and noncontrolling interest | (632,788) | (129,900) |
| Income tax (expense) benefit | (9) | 234 |
| Net loss | (632,797) | (129,666) |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s other income, net (note 6)?
- ImmunityBio, Inc. (IBRX) reported other income, net (note 6) of -$5.92M in Q1 2026.
- How has ImmunityBio, Inc.'s other income, net (note 6) changed year-over-year?
- ImmunityBio, Inc.'s other income, net (note 6) decreased by 14331.7% year-over-year, from -$41K to -$5.92M.
- What is the long-term trend for ImmunityBio, Inc.'s other income, net (note 6)?
- Over 2 years (2022 to 2025), ImmunityBio, Inc.'s other income, net (note 6) has grown at a 71.9% compound annual growth rate (CAGR), from -$736K to -$2.17M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about ImmunityBio, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude